eccogene glp 1 obtains exclusive license from AstraZeneca to develop and sell ECC5004, a GLP-1 receptor agonist for cardio-metabolic diseases Eccogene Enters Exclusive License Agreement

PMID 12612084

Sports Eligibility Risk : Athletes face eligibility concerns because WADA prohibits unapproved substances, and BPC-157 is commonly discussed within that restricted category

Its lower Gl leads to a slower, steadier increase in blood sugar, supporting better metabolic control

A more recent trial 4 suggests people with HIV and abdominal obesity may also see reductions in waist circumference and improvements in IGF-1, hinting at broader use for visceral fat accumulation

By choosing a high-quality, well-absorbed glutathione supplement, individuals can support their body's natural processes and maintain a balanced antioxidant system